Course Code: BP404T
Course Title: Pharmacology-I (Theory)
www.DuloMix.com
The objectives of the course are:
• To impart adequate knowledge and scientific information regarding basic
principles of Pharmaceutical Chemistry, Pharmaceutics (including
cosmetics), Pharmacology and Pharmacognosy (including Herbal drugs) to
develop and evaluate dosage forms
• To enhance the understanding of practical techniques to enable the
synthesis, manufacture and analysis of various formulations and herbal
medicines
• To impart adequate knowledge of practical aspects of Pharmacological
screening, biological standardization and in-vivo interactions to ensure
the safety and efficacy of the formulations
• To impart adequate knowledge of practical aspects to deliver quality
assured products as per the Pharmacopoeial standards
www.DuloMix.com 2
The objectives of the programme are:
• To provide adequate knowledge of practical aspects of product detailing
to optimize the marketing of Pharmaceutical products
• To enable the student to maintain a high standard of ethics and conduct
in professional career
• To facilitate the student to develop an attitude to seek lifelong learning
to update the knowledge and professional skills
• To enable the student to cope in various situations, irrespective of the
different cultures or constraints involved and develop leadership and
entrepreneurial skills
• To provide adequate knowledge about the Human Anatomy and
Physiology & to facilitate their understanding of various body systems
www.DuloMix.com 3
Why This Course
• The Pharmacology I course presents the fundamentals of drugs and their
Pharmacology
• Includes drugs acting on autonomic nervous system, central nervous
system and kidney
• Highlight Pharmacokinetics and Pharmacodynamics of individual drugs
• Emphasis the mechanism of action, pharmacological action, adverse drug
interactions, drug interactions and uses of drug
• Includes pre-clinical and clinical evaluations in the development of new
drugs
www.DuloMix.com 4
Course Aim and Summary
• The aim of this course is to educate students on drugs and their
actions on the human body and their therapeutic applications. This
course facilitates students to gain better understanding on
pharmacodynamics and pharmacokinetics of drugs and to
preparemthem for further study in the course discipline
www.DuloMix.com 5
Course Intended Learning Outcomes
• After undergoing this course students will be able to:
Sr no. Intended Learning Outcome
1 Define the terminologies used in pharmacology
2 Explain the pharmacokinetics and mechanism of drug action at organ system/sub
cellular/macromolecular levels
3 Outline the stages of drug development
4 Explain the pharmacology of drugs acting on Nervous System
5 Recognize adverse drug reactions and drug interactions
6 Discuss drug mechanisms and their relevance in the treatment of diseases
www.DuloMix.com 6
Course Content
General Pharmacology
a. Introduction to Pharmacology- Definition, historical landmarks and scope of
pharmacology, nature and source of drugs, essential drugs concept and routes of
drug administration, Agonists, antagonists( competitive and non competitive),
spare receptors, addiction, tolerance, dependence, tachyphylaxis, idiosyncrasy,
allergy.
b. Pharmacokinetics- Membrane transport, absorption, distribution, metabolism and
excretion of drugs:Enzyme induction, enzyme inhibition, kinetics of elimination
General Pharmacology
• Pharmacodynamics- Principles and mechanisms of drug action. Receptor theories
and classification of receptors, regulation of receptors. drug receptors interactions
signal transduction mechanisms, G-protein– coupled receptors, ion channel
receptor, transmembrane enzyme linked receptors, transmembrane JAK-STAT
binding receptor and receptors that regulate transcription factors, dose
response,relationship, therapeutic index, combined effects of drugs and factors
modifying drug action.
www.DuloMix.com 7
Course Content cont..
b. Adverse drug reactions
c. Drug interactions (pharmacokinetic and pharmacodynamics)
d. Drug discovery and clinical evaluation of new drugs -Drug discovery phase,
preclinical evaluation phase, clinical trial phase, phases of clinical trials and
pharmacovigilance
Pharmacology of drugs acting on peripheral nervous system
a. Organization and function of ANS
b.Neurohumoral transmission, co-transmission and classification of
neurotransmitters
c. Parasympathomimetics, Parasympatholytics, Sympathomimetics, sympatholytics.
d. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). e.
Local anesthetic agents
f. Drugs used in myasthenia gravis and glaucoma
www.DuloMix.com 8
Course Content cont..
Pharmacology of drugs acting on central nervous system
a.Neurohumoral transmission in the C.N.S.special emphasis on importance of
various neurotransmitters like with GABA, Glutamate, Glycine, serotonin,
dopamine
b. General anesthetics and pre-anesthetics
c. Sedatives, hypnotics and centrally acting muscle relaxants
d. Anti-epileptics
e. Alcohols and disulfiram
Pharmacology of drugs acting on central nervous system
a.Psychopharmacological agents: Antipsychotics, antidepressants, anti-anxiety
agents, anti-maniacs and hallucinogens.
b. Drugs used in Parkinson’s disease and Alzheimer’s disease
c. CNS stimulants and nootropics
d. Opioid analgesics and antagonists
e. Drug addiction, drug abuse, tolerance and dependence
www.DuloMix.com 9
Method of Assessment
• There are two components for assessment in this course:
• Component – 1: 25 Marks (CE)
• It has 3 sub components
• Part 1A: Attendance: 04 Marks
• Part 1B: Assignment : 06 Marks
• Part 1C: Sessional Examinations : 15 Marks
• Student is required to submit 1 word processed assignment which is set for 12
marks at the end of 14th week and the marks scored will be reduced to 6 marks.
• Two sessional exams (each for 30 marks) of 1 hour duration will be conducted,
one at the end of 6th week and the other at the end of the 12th week. The
average of the 2 sessional marks reduced to 15 will be the marks scored in the
Sessional Examination.
www.DuloMix.com 10
Method of Assessment
www.DuloMix.com 11
Method of Assessment Contd..
• Component – 2 : 75 Marks (SEE)
• A 3 hour duration Semester End Examination will be conducted for maximum marks
of 75.
• The assessment questions are set to test the learning outcomes. In each
component certain learning outcomes are assessed. The following table illustrates
the focus of learning
•Both components will bwewmwo.DdueloraMtiex.dcobmy a second examine12r.
References
Essential Reading
1. Class notes
2. Rang,M.P., Dale,M.M. and Riter, J.M. (2015) Pharmacology.8thedn. China: Churchill
Livingstone.
3. Katzung, B. G. (2009) Basic and Clinical Pharmacology.11thedn.NewDelhi:Tata
McGrawHill.
4. Tripathi, K.D. (2013) Essentials of Medical Pharmacology.7th edn. New Delhi: Jaypee
Brothers.
5. Sharma, H. L. and Sharma, K. K. (2011) Principles of Pharmacology. 2nd edn. New Delhi:
Paras Publishing.
www.DuloMix.com 13
References
• Recommended Reading
• 1. Rang, M. P., Dale, M. M. and Riter, J.M. (2015) Pharmacology. 8thedn. China:
Churchill Livingstone.
• 2. Katzung, B.G. (2009) Basic and Clinical Pharmacology.11thedn. New Delhi: Tata
McGraw Hill.
• 3. Goodman, L. S., Gilman, A., Brunton, L. L., Lazo, J. S. and Parker, K. L.(ed.) (2011)
Goodman and
• Gilman’s The Pharmacological Basis of Therapeutics. 12th edn. New York: McGraw Hill
Education.
• 4. Marry Anne, K. K., Lloyd Yee, Y., Brian, K. A., Robbin, L.C., Joseph, G. B., Wayne, A. K.,
Bradley, R.W. (2011) Applied Therapeutics, The Clinical use of Drugs. 10th edn., USA:
Lippincott Williams & Wilkins.
www.DuloMix.com 14
5. Michelle, A. C., Richard, F., Jose, A. R. and Karen, W. (ed.) (2011)
Lippincott’s Illustrated Reviews Pharmacology. 5th edn. China:
Lippincott Williams & Wilkins.
6. Tripathi, K.D. (2013) Essentials of MedicalPharmacology.7th edn.
New Delhi: Jaypee Brothers.
7. Sharma, H. L. and Sharma, K. K. (2011) Principles of Pharmacology.
2nd edn. New Delhi: Paras Publishing.
8. Stitzel, R. E., Craig, C. R. (2012) Modern Pharmacology with Cinical
Applications. 6th edn. USA: Lippincott Williams & Wilkins.
9. Ghosh, M. N. (2008)Fundamentals of Experimental Pharmacology.
6th edn. Kolkata: Hilton & Company.
10. Kulkarni, S. K. (2010) Handbook of Experimental Pharmacology.3rd
edn. Delhi: Vallabh Prakashan.
www.DuloMix.com 15
Magazines and Journals
1. Indian Journal of Pharmacology. Mumbai: Wolters Kluwer –
Medknow Publications
2. Journal of Pharmacy and Pharmacology. UK: Royal Pharmaceutical
Society
3. Indian Drugs. Mumbai: Indian Drug Manufacturers Association
4. Drug USA: Springerlink
5. ICH, OECD and USFDA Guidelines
Websites
• 1. www.icp.org.nz
• 2. www.craigslist.org
• 3. www. druglib.com
www.DuloMix.com 16
e. Other electronics Resources
1. Kathryn l. Mccance, RN, and Sue E. Huether, Pathophysiology Online
for Pathophysiology, 6th Edition, The biologic Basis for Disease in
Adults and Children, College of Nursing University of Utah,Salt Lake
City, UT.
2. Esther Chang, John Daly, Doug Elliot (2006) Pathophysiology Applied
to Nursing Practice, Australia: Elsevier.
www.DuloMix.com 17
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
01 28-Jan-2019 03:00 to 04:00 Monday Orientation Dr.Kesha Desai
02 30-Jan-2019 12:00 to 01:00 Wednesday Introduction Dr.Kesha Desai
03 31-Jan-2019 10:00 to 11:00 Thursday Routes of administration Dr.Kesha Desai
04 4-Feb-2019 03:00 to 04:00 Monday Absorption, Distribution Dr.Kesha Desai
05 6-Jan-2019 12:00 to 01:00 Wednesday Biotransformation Dr.Kesha Desai Demo using
Video
06 7-Jan-2019 10:00 to 11:00 Thursday Pkinetics Dr.Kesha Desai Tutorial
07 9-Feb-2019 09:00 to 10:00 Saturday Pharmacodynamics Dr.Kesha Desai Tutorial
08 11-Feb-2019 03:00 to 04:00 Monday Pharmacodynamics Dr.Kesha Desai Demo using
Video
09 13-Feb-2019 12:00 to 01:00 Wednesday Pharmacodynamics Dr.Kesha Desai
10 14-Feb-2019 10:00 to 11:00 Thursday MG Dr.Kesha Desai
www.DuloMix.com 18
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
11 16-Feb-2019 09:00 to Saturday ADR Dr.Kesha Desai
10:00
12 18-Feb-2019 03:00 to Monday Drug tol & interaction Dr.Kesha Desai
04:00
13 20-Feb-2019 12:00 to Wednesday Local anaesthetics Dr.Kesha Desai Demo using
01:00 Video
14 21-Feb-2019 10:00 to Thursday ANS Dr.Kesha Desai
11:00
15 23-Feb-2019 09:00 to Saturday ANS Dr.Kesha Desai Tutorial
10:00
16 25-Feb-2019 03:00 to Monday ANS Dr.Kesha Desai Demo using
04:00 Video
17 27-Feb-2019 12:00 to Wednesday ANS Dr.Kesha Desai
01:00
18 28 Feb-2019 10:00 to Thursday ANS Dr.Kesha Desai
11:00
19 4-Mar-2019 03:00 to Monday ANS Dr.Kesha Desai
04:00
www.DuloMix.com 19
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
20 6-Mar-2019 12:00 to Wednesday ANS Dr.Kesha Desai
01:00
21 7-Mar-2019 10:00 to Thursday ANS Dr.Kesha Desai
11:00
22 9 Mar 2019 09:00to Saturday ANS Dr.Kesha Desai
10:00
11-Mar-2019 TERM TEST 1
22 18-Mar-2019 03:00 to Monday NHT Dr.Kesha Desai
04:00
23 21-Mar-2019 10:00 to Thursday CNS-GA Dr.Kesha Desai
11:00
24 23-Mar-2019 09:00to Saturday CNS-GA Dr.Kesha Desai Demo using
10:00 Video
25 25-Mar-2019 03:00 to Monday CNS-SED Dr.Kesha Desai Assignment
04:00 Submisssion
26 27-Mar-2019 12:00 to Wednesday CNS-ANX Dr.Kesha Desai
01:00
27 28-Mar-2018 10:00 to Thursday CNS-EPI Dr.Kesha Desai Demo using
11:00 Video
www.DuloMix.com
28 30-Mar-2018 09:00 to Saturday CNS-EPI 20
Dr.Kesha Desai
10:00
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
29 1-Apr-2019 03:00 to Monday CNS-Alcohol Dr.Kesha Desai
04:00
30 3-Apr-2019 12:00 to Wednesday CNS-PSYCHO Dr.Kesha Desai Demo using
01:00 Video
31 4-Apr-2019 10:00 to Thursday CNS-PSYCHO Dr.Kesha Desai
11:00
32 8-Apr-2019 09:00 to Monday Affective diorders Dr.Kesha Desai
10:00
33 10-Apr-2019 02:00 to Wednesday Affective diorders Dr.Kesha Desai
03:00
34 11-Apr-2019 09:00 to Thursday Affective diorders Dr.Kesha Desai Tutorial
10:00
35 13-Apr-2019 09:00 to Saturday Parkinsonism Dr.Kesha Desai
10:00
36 15-Apr-2019 03:00 to Monday Parkinsonism Dr.Kesha Desai Demo using
04:00 Video
37 17-Apr-2019 12:00 to Wednesday Alzheimer’s disease Dr.Kesha Desai
01:00
38 18-Apr-2019 10:00 to Thursday Alzheimer’s disease Dr.Kesha Desai Tutorial
11:00
www.DuloMix.com 21
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
39 20-Apr-2019 09:00 to Saturday Opioids Dr.Kesha Desai
10:00
40 22-Apr-2019 03:00 to Monday Opioids Dr.Kesha Desai
04:00
41 24-Apr-2019 12:00 to Wednesday CNS stimulants Dr.Kesha Desai
01:00
42 25-Apr-2019 10:00 to Thursday Opioids Dr.Kesha Desai
11:00
43 27-Apr-2019 09:00 to Saturday Skeletal muscle Dr.Kesha Desai
10:00 relaxant
29-Apr-2019 TERM TEST 2
44 08-May-2019 12:00 to Wednesday Preclinical studies Dr.Kesha Desai
01:00
45 09-May-2019 10:00 to Thursday Preclinical studies Dr.Kesha Desai
11:00
www.DuloMix.com 22
Course Delivery Schedule
Lecture Date Time Day Topic Delivered By Additional
No. Activity
46 11-May-2019 09:00 to Saturday Clinical studies Dr.Kesha Desai Demo using
10:00 Video
47 13-May-2019 03:00 to Monday Clinical studies Dr.Kesha Desai Tutorial
04:00
48 15-May-2019 12:00 to Wednesday Pharmacovigilance Dr.Kesha Desai Demo using
01:00 Video
49 16-May-2019 10:00 to Thursday Revision Dr.Kesha Desai
11:00
50 18-May-2019 09:00 to Saturday Revision Dr.Kesha Desai
10:00
Semester end examinations
www.DuloMix.com 23
Lecture 1
Objectives
At the end of this lecture, student will be able to
• Describe Pharmacology
• Explain the sources of drugs
• Discuss the scope of pharmacology
www.DuloMix.com 24
Lecture 2
Objectives
At the end of this lecture, student will be able to
• Classify various routes of administration
• Explain the advantages and disadvantages of various routes of
administration
• Differentiate between oral and parenteral route of administration
www.DuloMix.com 25
Lecture 3
Objectives
At the end of this lecture, student will be able to
• Explain absorption and bioavailability
• Describe mechanisms of drug transport
• Explain the factors affecting absorption and bioavailability of drugs
www.DuloMix.com 26
Lecture 4
Objectives
At the end of this lecture, student will be able to
• Explain the process of drug distribution
• Describe protein binding
• Explain volume of distribution
• Outline the barriers to drug passage
www.DuloMix.com 27
Lecture 5
Objectives
At the end of this lecture, student will be able to
• Explain chemical pathways of biotransformation
• Differentiate between phase I and phase II metabolism
• Outline microsomal and non microsomal enzymes
• Explain the process of first pass metabolism
www.DuloMix.com 28
Lecture 6
Objectives
At the end of this lecture, student will be able to
• Describe enzyme induction and inhibition
• Give examples for clinically significant enzyme induction and
inhibition
• Explain the factors affecting drug metabolism
• Differentiate between first and zero order kinetics
www.DuloMix.com 29
Lecture 7
Objectives
At the end of this lecture, student will be able to
• Explain principles of drug action
• Explain mechanisms involved in drug action
• Describe enzyme inhibition process
www.DuloMix.com 30
Lecture 08
Objectives
At the end of this lecture, student will be able to
• Describe Receptor
• Describe G – Protein coupled receptor
• Explain effector pathways of GPCR
www.DuloMix.com 31
Lecture 09
Objectives
At the end of this lecture, student will be able to
• Describe ion channel receptor, enzyme linked receptor and
receptors regulating gene expression
• Explain the functions of receptors
• Differentiate between synergism and antagonism
www.DuloMix.com 32
Lecture 10
Objectives
At the end of this lecture, student will be able to
• Differentiate between side effects and toxic effects
• Classify Adverse Drug Reactions
• Describe hypersensitivity reactions
• Explain the factors modifying drug effects
www.DuloMix.com 33
Lecture 11
Objectives
At the end of this lecture, student will be able to
• Explain myasthenia gravis, its diagnosis and treatment
• Differentiate between mydriatics and miotics
• Outline the treatment of glaucoma
• Explain the pharmacology of ganglionic stimulants
www.DuloMix.com 34
Lecture 12
Objectives
At the end of this lecture, student will be able to
• Describe drug interactions
• Give examples for drug interactions inside/outside the body
• Explain drug tolerance and dependence
www.DuloMix.com 35
Lecture 13
Objectives
At the end of this lecture, student will be able to
• Classify local anesthetics
• Describe the general properties of local anesthetics
• Explain the pharmacology of local anesthetics
• Explain spinal anesthesia
www.DuloMix.com 36
Lecture 14
Objectives
At the end of this lecture, student will be able to
• Describe the autonomic nervous system
• Differentiate between sympathetic and parasympathetic nervous
system
• Explain neurohumoral transmission
• Explain location, function and characterisation of cholinergic
receptors
www.DuloMix.com 37
Lecture 15
Objectives
At the end of this lecture, student will be able to
• Classify General anesthetics
• Differentiate between inhalational and intravenous anesthetics
• Describe the various sites and mechanism of action of anesthetics
• Explain the stages of anesthesia
www.DuloMix.com 38
Lecture 16
Objectives
At the end of this lecture, student will be able to:
• Give examples for non volatile anaesthetics
• Explain the pharmacological actions of thiopental
• List the uses of ketamine
• Describe neuroleptanalgesis
www.DuloMix.com 39
Lecture 17
Objectives
At the end of this lecture, student will be able to:
• Give example for inhalational anesthetics
• Explain the pharmacology of diethyl ether and nitrous oxide
• List the advantages and disadvantages of diethyl ether and nitrous
oxide
www.DuloMix.com 40
Lecture 18
Objectives
At the end of this lecture, student will be able to:
• Differentiate between sedatives and hypnotics
• Classify barbiturates
• Explain the pharmacology of barbiturates
• Outline the symptoms of barbiturate poisoning and its treatment
www.DuloMix.com 41
Lecture 19
Objectives
At the end of this lecture, student will be able to:
• Differentiate between sedatives and hypnotics
• Classify sedatives and hypnotics
• Explain the pharmacology of benzodiazepines
• List the advantages of benzodiazepines as sedative and hypnotic
www.DuloMix.com 42
Lecture 20
Objectives
At the end of this lecture, student will be able to
•Classify anxiolytics, psychomotor stimulants and psychotogenic drugs
•List the uses of psychomotor stimulants
•Explain the pharmacology of LSD and cannabis
•Differentiate psychomotor stimulants and psychotogenic drugs
Lecture 21
Objectives
At the end of this lecture, student will be able to:
• Classify antiepileptic drugs
• Explain the various types of epilepsy
• Describe the neurophysiology of epilepsy
• Differentiate generalized and partial seizures
www.DuloMix.com 44
Lecture 22
Objectives
At the end of this lecture, student will be able to
•Classify antiepileptics therapeutically
•Explain the neurophysiology of epilepsy
•Explain the mechanism, pharmacological actions and
ADRs of phenytoin
Lecture 23
Objectives
At the end of this lecture, student will be able to
•List the uses of phenytoin
•Explain the drug interaction with phenytoin
•Explain the pharmacological actions of barbiturates, carbamazepine,
valproic acid, GABA transaminase inhibitors
Lecture 24
Objectives
At the end of this lecture, student will be able to
•Explain acute alcohol intoxication
•Explain methanol poisoning and its treatment
•Outline the mechanism of disulfiram
•List the drugs used for the treatment of alcohol dependence
Lecture 25
Objectives
At the end of this lecture, student will be able to
•Explain the mechanism of ethanol
•Explain the pharmacological actions and uses of ethanol
•List the aldehyde dehydrogenase inhibitors
Lecture 26
Objectives
At the end of this lecture, student will be able to
•Differentiate between psychotic and neurotic disorders
•Classify psychotropics and antipsyhotics
•Explain the mechanism and pharmacological actions of chlorpromazine
Lecture 27
Objectives
At the end of this lecture, student will be able to
• Explain the pharmacological actions, ADME and ADR of
chlorpromazine
• Explain the pharmacological actions of reserpine
• Give examples for atypical antipsychotics
• List the advantages of atypical antipsychotics
www.DuloMix.com 50
Lecture 28
Objectives
At the end of this lecture, student will be able to
• Explain the pathophysiology of Schizophrenia
• Describe the symptoms of Schizophrenia
• Explain dopamine pathways involved in schizophrenia
• Enumerate the role of neurotransmitter system in schizophrenia
www.DuloMix.com 51
Lecture 29
Objectives
At the end of this lecture, student will be able to
• Explain the pathophysiology of Depression
• Describe the symptoms of Depression
• Explain the Pharmacological actions, ADR, interactions and uses of
various anti-depressants
• Discuss on Newer antidepressants and their advantages
• Explain the treatment of Depression
www.DuloMix.com 52
Lecture 30
Objectives
At the end of this lecture, student will be able to
• Explain the pathophysiology of Mania
• Describe the symptoms and types of Mania
• Explain the Pharmacological actions, ADR, interactions and uses of
various anti-maniacs
• Explain the treatment of Mania
www.DuloMix.com 53
Lecture 31
Objectives
At the end of this lecture, student will be able to
• Classify antidepressants
• Give examples MAOIs
• Explain the pharmacology of MAOIs
• Explain the actions tricyclic antidepressants
• Classify antimanic drugs
www.DuloMix.com 54
Lecture 32
Objectives
At the end of this lecture, student will be able to
• Classify antidepressants
• Give examples MAOIs
• Explain the pharmacology of MAOIs
• Explain the actions tricyclic antidepressants
• Classify antimanic drugs
www.DuloMix.com 55
Lecture 33
Objectives
At the end of this lecture, student will be able to
• Classify Anti Prakinson’s drugs therapeutically
• Explain the mechanism, pharmacological actions and ADRs of
antiparkinson drugs
• Non-pharmacological management
www.DuloMix.com 56
Lecture 34
Objectives
At the end of this lecture, student will be able to
• Classify Anti Prakinson’s drugs therapeutically
• Explain the neurophysiology of Parkinson’s
• Explain the mechanism, pharmacological actions and ADRs of
Levodopa
www.DuloMix.com 57
Lecture 35
Objectives
At the end of this lecture, student will be able to
• Explain pathophysiology of Alzheimer disease
• Describe sign and symptoms of Alzheimer disease
• Classify drugs used in Alzheimer disease
www.DuloMix.com 58
Lecture 36
Objectives
At the end of this lecture, student will be able to
• Describe the stages of Alzheimer’s Disease
• Explain the etiology of Alzheimer’s Disease
• Elaborate the stages of Alzheimer’s Disease
www.DuloMix.com 59
Lecture 37
Objectives
At the end of this lecture, student will be able to
• Describe the laboratory tests for Alzheimer’s Disease
• Explain therapeutic management of Alzheimer’s Disease
• Discuss the Pharmacological actions of drugs
www.DuloMix.com 60
Lecture 38
Objectives
At the end of this lecture, student will be able to
• Explain the pathophysiology of Alzheimer’s Disease
• Explain the pharmacology of drugs used in Alzheimer’s Disease
• Discuss the treatment of Alzheimer’s Disease
• Enumerate the adverse effects of drugs used in the treatment of
Alzheimer’s Disease
www.DuloMix.com 61
Lecture 39
Objectives
At the end of this lecture, student will be able to
• Describe pain pathways
• Classify opioid analgesics
• Explain the pharmacology of opioid analgesics
• Describe acute morphine poisoning
• Explain the pharmacology of opioid antagonists
www.DuloMix.com 62
Lecture 40
Objectives
At the end of this lecture, student will be able
• Describe CNS Stimulants
• Classify opioid analgesics
• Explain the pharmacology of opioid analgesics
• Describe acute morphine poisoning
www.DuloMix.com 63
Lecture 41
Objectives
At the end of this lecture, student will be able to
• Describe the autonomic nervous system
• Differentiate between sympathetic and parasympathetic nervous
system
• Explain neurohumoral transmission
• Explain location, function and characterisation of cholinergic
receptors
www.DuloMix.com 64
Lecture 42
Objectives
At the end of this lecture, student will be able to
• Describe the autonomic nervous system
• Explain neurohumoral transmission
• Explain location, function and characterisation of cholinergic
receptors
www.DuloMix.com 65
Lecture 43
Objectives
At the end of this lecture, student will be able to
• List the cholinergic drugs
• Explain the pharmacology of acetylcholine
• Describe pharmacokinetic of ACh
www.DuloMix.com 66
Lecture 44
Objectives
At the end of this lecture, student will be able to
• List the cholinergic drugs
• Explain organophophorous poisoning
• Describe treatment of poisoning
www.DuloMix.com 67
Lecture 45
Objectives
At the end of this lecture, students will be able to-
• List the anticholinergic drugs
• Explain the pharmacology of atropine
• Explain atropine poisoning and its treatment
www.DuloMix.com 68
Lecture 46
Objectives
At the end of this lecture, students will be able to:
• Classify adrenergic drugs
• Describe sympathetic receptors
• Explain the pharmacology of adrenaline and Noradrenaline
www.DuloMix.com 69
Lecture 47
Objectives
At the end of this lecture, students will be able to –
• List the adrenergic drugs
• Describe sympathetic receptors
• Explain the pharmacology of adrenaline and Noradrenaline
www.DuloMix.com 70
Lecture 48
Objectives
At the end of this lecture, students will be able to –
• List the adrenergic drugs
• Describe sympathetic receptors
• Explain the pharmacology of adrenaline and Noradrenaline
www.DuloMix.com 71
Lecture 49
Objectives
At the end of this lecture, students will be able to –
• Differentiate between alpha and beta receptor blockers
• Explain the pharmacology of propranolol
• Pharmacokinetic of beta-blockers
www.DuloMix.com 72
Lecture 50
Objectives
At the end of this lecture, students will be able to –
• Differentiate between catecholamines and non catecholamines
• Explain the ADME of adrenaline and noradrenaline
• Explain the pharmacology of dopamine
• Explain the pharmacology of ephedrine
www.DuloMix.com 73
Lecture 51
Objectives
At the end of this lecture, students will be able to –
• Explain the pharmacology of ephedrine
• Explain nasal decongestants, selective α2 and β2 receptor stimulants
www.DuloMix.com 74
Lecture 52
Objectives
At the end of this lecture, students will be able to –
• Classify sympatholytics
• Differentiate between alpha and beta receptor blockers
• Explain the pharmacology of propranolol
www.DuloMix.com 75
Lecture 53
Objectives
At the end of this lecture, students will be able to –
• Classify muscle relaxants
• Differentiate between centrally acting and peripherally acting
muscle relaxants
• Explain the pharmacology of tubocurarine
• Give example for persistent depolarising muscle relaxant
www.DuloMix.com 76
Lecture 54
Objectives
At the end of this lecture, students will be able to –
• Explain the stages of preclinical studies
• Outline pharmacodynamic studies
• Explain toxicity studies
• Discuss the assessment of safety index
www.DuloMix.com 77
Lecture 55
Objectives
At the end of this lecture, students will be able to –
• Explain the stages of clinical studies
• DescribePostmarketing studies
• Discuss the assessment of safety index